SUZUKEN CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,531 JPY | -0.98% |
|
-0.26% | -2.87% |
| Sales 2024 * | 2,325B 15.02B | Sales 2025 * | 2,364B 15.27B | Capitalization | 355B 2.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 23.56B 152M | Net income 2025 * | 21.13B 137M | EV / Sales 2024 * | 0.15 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.15 x |
| P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
17.1
x | Employees | 13,429 |
| Yield 2024 * |
1.7% | Yield 2025 * |
1.7% | Free-Float | 71.32% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.90% | ||
| 1 week | -0.26% | ||
| Current month | -2.24% | ||
| 1 month | -1.22% | ||
| 3 months | -3.30% | ||
| 6 months | -1.22% | ||
| Current year | -2.87% |
1 week
4 358.00
4 599.00
1 month
4 358.004 705.00
Current year
4 358.005 020.00
1 year
3 475.005 137.00
3 years
2 963.005 137.00
5 years
2 963.007 040.00
10 years
2 514.557 040.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shigeru Asano
PSD | President | 57 | 90-03-31 |
Hiromi Miyata
CHM | Chairman | 64 | 84-03-31 |
| Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shunichi Samura
BRD | Director/Board Member | 78 | 21-05-31 |
Toshiaki Iwatani
BRD | Director/Board Member | 62 | 94-05-31 |
| Director/Board Member | 70 | 21-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.86% | 32 M€ | +28.65% | ||
| 0.11% | 1,120 M€ | +0.77% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 4,531 | -0.98% | 48 800 |
| 24-04-23 | 4,576 | +0.86% | 222,400 |
| 24-04-22 | 4,537 | +2.69% | 207,500 |
| 24-04-19 | 4,418 | -2.39% | 259,700 |
| 24-04-18 | 4,526 | -0.46% | 182,800 |
Delayed Quote Japan Exchange, April 23, 2024 at 09:31 pm EDT
More quotes
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4,576
JPY
Average target price
4,720
JPY
Spread / Average Target
+3.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.87% | 2.28B | |
| +14.88% | 69.29B | |
| +3.18% | 8.36B | |
| +5.20% | 8.16B | |
| -20.43% | 7.69B | |
| +0.73% | 4.53B | |
| +16.98% | 4.47B | |
| -2.00% | 3.99B | |
| -2.89% | 3.88B | |
| +21.87% | 3.66B |
- Stock Market
- Equities
- 9987 Stock
